Benjamin Seltzer

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Donepezil: an update
    Ben Seltzer
    V A Boston Healthcare System, Department of Neurology, Harvard Medical School, Geriatric Research Center, Boston, MA 02130, USA
    Expert Opin Pharmacother 8:1011-23. 2007
  2. ncbi request reprint Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?
    Ben Seltzer
    Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA
    Drugs Aging 24:881-90. 2007
  3. doi request reprint Posterior cingulate and retrosplenial cortex connections of the caudal superior temporal region in the rhesus monkey
    Benjamin Seltzer
    VA Boston Healthcare System, Department of Neurology, Harvard Medical School, Boston, MA 02130, USA
    Exp Brain Res 195:325-34. 2009
  4. pmc Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease
    Ben Seltzer
    Geriatric Research, Education and Clinical Center, V A Boston Healthcare System, Department of Neurology, Harvard Medical School, Boston, MA, USA
    Clin Interv Aging 5:1-6. 2010
  5. ncbi request reprint Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial
    Ben Seltzer
    Department of Psychiatry and Neurology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112 2699, USA
    Arch Neurol 61:1852-6. 2004
  6. ncbi request reprint Donepezil: a review
    Ben Seltzer
    Tulane University School of Medicine, Department of Psychiatry and Neurology, 1430 Tulane Avenue HC82, New Orleans, Louisiana 70112, USA
    Expert Opin Drug Metab Toxicol 1:527-36. 2005
  7. ncbi request reprint Cognitive components of deficit awareness in Alzheimer's disease
    Lisa M Duke
    Mental Health Service Line, Veterans Affairs Medical Center, New Orleans, Louisiana, USA
    Neuropsychology 16:359-69. 2002

Collaborators

  • Lisa M Duke
  • Jennifer J Vasterling
  • Jennifer E Seltzer

Detail Information

Publications7

  1. ncbi request reprint Donepezil: an update
    Ben Seltzer
    V A Boston Healthcare System, Department of Neurology, Harvard Medical School, Geriatric Research Center, Boston, MA 02130, USA
    Expert Opin Pharmacother 8:1011-23. 2007
    ..However, in general, the efficacy of donepezil is limited, and ongoing studies are investigating other agents that may ultimately overtake its present position as the mainstay of anti-AD therapy...
  2. ncbi request reprint Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?
    Ben Seltzer
    Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA
    Drugs Aging 24:881-90. 2007
    ..The most contentious issue regarding long-term treatment is economic, but the majority of available economic analyses suggest net savings over the long term if patients with AD receive persistent treatment with ChEIs...
  3. doi request reprint Posterior cingulate and retrosplenial cortex connections of the caudal superior temporal region in the rhesus monkey
    Benjamin Seltzer
    VA Boston Healthcare System, Department of Neurology, Harvard Medical School, Boston, MA 02130, USA
    Exp Brain Res 195:325-34. 2009
    ..It is suggested that this connectional pattern of the caudal STG is consistent with its putative role of localizing sounds in space as proposed in recent studies...
  4. pmc Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease
    Ben Seltzer
    Geriatric Research, Education and Clinical Center, V A Boston Healthcare System, Department of Neurology, Harvard Medical School, Boston, MA, USA
    Clin Interv Aging 5:1-6. 2010
    ..Since its release onto the market galantamine-ER has enjoyed wide popularity and a recent surveillance study suggests that it has the highest 1-year persistence rate of all the ChEIs...
  5. ncbi request reprint Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial
    Ben Seltzer
    Department of Psychiatry and Neurology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112 2699, USA
    Arch Neurol 61:1852-6. 2004
    ..To evaluate the efficacy of donepezil in patients with early-stage Alzheimer disease...
  6. ncbi request reprint Donepezil: a review
    Ben Seltzer
    Tulane University School of Medicine, Department of Psychiatry and Neurology, 1430 Tulane Avenue HC82, New Orleans, Louisiana 70112, USA
    Expert Opin Drug Metab Toxicol 1:527-36. 2005
    ..Although donepezil was originally developed to inhibit the breakdown of the neurotransmitter acetylcholine as symptomatic therapy for AD, recent studies raise the possibility of other effects this drug has on the pathogenesis of AD...
  7. ncbi request reprint Cognitive components of deficit awareness in Alzheimer's disease
    Lisa M Duke
    Mental Health Service Line, Veterans Affairs Medical Center, New Orleans, Louisiana, USA
    Neuropsychology 16:359-69. 2002
    ..AD patients may display intact immediate awareness of memory dysfunction but fail to incorporate incidents of memory failure into generalized self-belief systems...